Free testosterone measurement quantifies the biologically active fraction of the androgen testosterone that is unbound to plasma proteins, primarily Sex Hormone-Binding Globulin (SHBG) and albumin. This unbound hormone is readily available to diffuse into target cells and interact with androgen receptors, making it the most clinically relevant indicator of androgen status and tissue effect. It offers a more accurate assessment of functional hypogonadism than total testosterone alone.
Origin
The necessity for this specific measurement arose from the realization in the mid-20th century that total hormone concentration does not fully represent the bioavailable hormone pool due to protein binding. The concept of “free” hormone provided a crucial refinement in endocrinology, shifting diagnostic focus to the portion capable of eliciting a physiological response. This advancement led to more precise diagnosis and titration of Testosterone Replacement Therapy (TRT).
Mechanism
In the circulation, most testosterone is sequestered by SHBG, which renders it biologically inert. The small percentage that remains unbound constitutes the free fraction, which can directly traverse cell membranes. Measurement typically involves equilibrium dialysis or mass spectrometry techniques, providing a direct quantification of this potent, active hormone fraction. This precision allows for clinical assessment of receptor saturation and androgenic effect.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.